The deal remains subject to approval from the relevant antitrust authorities and the fulfillment of closing conditions under the share purchase agreement.
1 Synthetic pharmaceutical intermediates and active ingredients: Intermediates and active ingredients for pharmaceutical products that are produced by chemical synthesis.
2 CDMO: Contract development and manufacturing organization (a company that manufactures and develops production methods under contract for other companies).
3 cGMP: current Good manufacturing practice (standards governing the production and quality control of pharmaceutical and quasi-drugs).
AGC Inc.(Headquarters: Tokyo, President & CEO: Takuya Shimamura) is the parent company of the AGC Group, a world-leading glass solution provider and supplier of flat, automotive and display glass, chemicals, ceramics and other high-tech materials and components. Based on more than a century of technical innovation, the AGC Group has developed a wide range of cutting-edge products. The AGC Group employs some 50,000 people worldwide and generates annual sales of approximately 1.5 trillion Japanese yen through business in about 30 countries. For more information, please visit
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention. Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. More information about Boehringer Ingelheim can be found on or in the annual report: .
|Company||Malgrat Pharma Chemicals, S.L.U.|
Boehringer Ingelheim España, S.A. 100%
After acquisition by AGC
|Business description||Manufacture and sale of active pharmaceutical ingredients|